John Armitage
Egerton Capital
John Armitage HERBALIFE LTD stake
total: 222
Egerton Capital HLF trades
- Total transactions:
- 3
- New positions:
- 1
- Sold out:
- 1
- Reduced:
- 1
- Held since:
- 2021 Q3
- Held for:
- 2 quarters
- Latest activity:
- 2022 Q1
According to 2026 Q2 report, John Armitage doesn't hold any HERBALIFE LTD (HLF) shares. To date, the estimated cost basis is nearly $42.38 for "buy" trades and estimated average "sell" price is $40.93. Egerton Capital first purchased HLF in 2021 Q3, initially acquiring about 2.22M shares. Since the initial investment in HERBALIFE LTD (HLF), Egerton Capital has made 2 more transactions.
When did John Armitage sell HERBALIFE LTD (HLF)?
John Armitage sold off the entire HERBALIFE LTD (HLF) position in 2022 Q1.
When did John Armitage buy HERBALIFE LTD (HLF)?
John Armitage first invested in HERBALIFE LTD (HLF) in 2021 Q3 at the reported quarter-end price of $42.38 per share.
What's the cost basis of Egerton Capital's HLF stake?
The estimated cost basis for HERBALIFE LTD (HLF) stake is around $42.38 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $42.38
- Weighted AVG sell price:
- $40.93
John Armitage's historical trades in HERBALIFE LTD
3 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2022 Q1
|
0.00%
|
0
|
$40.93
|
|
-100% (-2,178,812)
|
-0.42%
|
|
2021 Q4
|
0.42%
|
2,178,812
|
$40.93
|
$89,179,000
|
-2.04% (-45,272)
|
-0.01%
|
|
2021 Q3
|
0.45%
|
2,224,084
|
$42.38
|
$94,257,000
|
new
|
+0.45%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.